Interior of Washington State House of Representatives chamber
340B healthcare providers have turned to the states to address challenges to the drug discount program, 340B Report Publisher and CEO Ted Slafsky says.

340B Report Publisher and CEO: Momentum for 340B Protections Is Growing

Safety net healthcare providers increasingly have turned to the states to address challenges to the 340B program, 340B Report Publisher and CEO Ted Slafsky says in his latest column for medication management solutions company Omnicell.

“In just four years, an impressive 21 states have passed or modified state laws preventing pharmacy benefit managers (PBMs) and other commercial payers from reimbursing 340B providers at a lower rate than other pharmacies,” Slafsky notes. He also takes a closer look at a growing effort by state governments to try to require drug manufacturers to provide 340B discounts in the contract pharmacy setting.

Despite this success, advocates say there is still a need for a federal remedy, Slafsky says. He describes a bill in Congress that would prevent a range of PBM practices that discriminate against 340B entities and require the government to contract with a third party to review claims for duplicate 340B discounts and Medicaid rebates on the same drugs.

You can read the entire article here.